Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.42 |
| ▸ | CA1 | P00915 | 7/20 | 0.42 |
| ▸ | CA9 | Q16790 | 5/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2293098 | 0.78 | CA1 (0.35) | CA2CA1CA9 | |
| SCHEMBL188294 | 0.74 | CA1 (0.30) | CA2CA1CA7CA13 | |
| SCHEMBL7235023 | 0.74 | USP2 (0.32) | — | |
| SCHEMBL8821770 | 0.74 | — | — | |
| SCHEMBL720897 | 0.71 | — | — | |
| SCHEMBL8884442 | 0.70 | — | — | |
| Lithium Ion SCHEMBL8821827 | 0.70 | — | — | |
| SCHEMBL28509909 | 0.69 | CA1 (0.42) | CA2CA1CA9CA7CA13 | |
| SCHEMBL718798 | 0.69 | CA1 (0.42) | CA2CA1CA9CA7CA13 | |
| SCHEMBL29166868 | 0.67 | CA1 (0.40) | CA2CA1CA9CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3608328-B1 | METHOD FOR PRODUCING PHOSPHORYL IMIDE SALT, METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SAID SALT, AND METHOD FOR PRODUCING NONAQUEOUS SECONDARY BATTERY | CENTRAL GLASS CO LTD (JP) | 2023-04-26 | — | — | EP | disclosed |
| US-11230564-B2 | Method for producing phosphoryl imide salt, method for producing nonaqueous electrolyte solution containing said salt, and method for producing nonaqueous secondary battery | CENTRAL GLASS CO., LTD. (JP) | 2022-01-25 | — | — | US | disclosed |
| US-20210054005-A1 | METHOD FOR PRODUCING PHOSPHORYL IMIDE SALT, METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SAID SALT, AND METHOD FOR PRODUCING NONAQUEOUS SECONDARY BATTERY | CENTRAL GLASS CO., LTD. (JP) | 2021-02-25 | — | — | US | disclosed |
| US-10851124-B2 | Method for producing phosphoryl imide salt, method for producing nonaqueous electrolyte solution containing said salt, and method for producing nonaqueous secondary battery | CENTRAL GLASS CO., LTD. (JP) | 2020-12-01 | — | — | US | disclosed |
| US-20200115401-A1 | METHOD FOR PRODUCING PHOSPHORYL IMIDE SALT, METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SAID SALT, AND METHOD FOR PRODUCING NONAQUEOUS SECONDARY BATTERY | CENTRAL GLASS CO., LTD. (JP) | 2020-04-16 | — | — | US | disclosed |
| EP-3608328-A1 | METHOD FOR PRODUCING PHOSPHORYL IMIDE SALT, METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SAID SALT, AND METHOD FOR PRODUCING NONAQUEOUS SECONDARY BATTERY | Central Glass Co., Ltd. (JP) | 2020-02-12 | — | — | EP | disclosed |
| CN-110520431-A | The manufacturing method of the manufacturing method of phosphorimide salt, the manufacturing method of nonaqueous electrolytic solution comprising the salt and non-aqueous secondary batteries | CENTRAL GLASS CO LTD | 2019-11-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11230564-B2 | Method for producing phosphoryl imide salt, method for producing nonaqueous electrolyte solution containing said salt, and method for producing nonaqueous secondary battery | PPM1F, PHOSPHO1, IPMK | CA2 134/4885CA1 322/4885CA9 351/4885 |
| US-10851124-B2 | Method for producing phosphoryl imide salt, method for producing nonaqueous electrolyte solution containing said salt, and method for producing nonaqueous secondary battery | PPM1F, PHOSPHO1, IPMK | CA2 134/4885CA1 322/4885CA9 351/4885 |
| US-20210054005-A1 | METHOD FOR PRODUCING PHOSPHORYL IMIDE SALT, METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SAID SALT, AND METHOD FOR PRODUCING NONAQUEOUS SECONDARY BATTERY | PPM1F, PHOSPHO1, IPMK | CA2 134/4885CA1 322/4885CA9 351/4885 |
| US-20200115401-A1 | METHOD FOR PRODUCING PHOSPHORYL IMIDE SALT, METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SAID SALT, AND METHOD FOR PRODUCING NONAQUEOUS SECONDARY BATTERY | PPM1F, PHOSPHO1, IPMK | CA2 134/4885CA1 322/4885CA9 351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.